Skip to content
sugarisadrug.com
  • Home
  • Diabetes
  • Health News
  • General Sugar
  • Food Choices
  • Insulin
  • Mental Health
  • Stop Eating Sugar
  • Stop Killing Yourself
  • Fructose
  • Sugar Science

Author: sugaradmin

Key Changes From CDC Panel

September 23, 2025 by sugaradmin

Share on PinterestA new CDC panel voted to make changes to childhood vaccination schedules and further narrow recommendations for COVID-19 shots. Shutterstock The CDC’s vaccine panel, ACIP, changed its recommendations for childhood vaccines and updated COVID-19 shots, further limiting access. The changes align with vaccine skepticism within the Trump administration. HHS Secretary RFK Jr. reformed […]

Read More
Health NewsLeave a Comment on Key Changes From CDC Panel

Does Tylenol Cause Autism? Here’s What the Science Says

September 22, 2025 by sugaradmin

Share on PinterestThe Tylenol-autism link is based on a research review that determined an association, but most studies have found no causal link. Getty Images The Trump administration has linked Tylenol use during pregnancy to autism in children and said the FDA will notify physicians to encourage pregnant people to limit their acetaminophen use. The […]

Read More
Health NewsLeave a Comment on Does Tylenol Cause Autism? Here’s What the Science Says

Diabetes Core Update : Special Edition

September 22, 2025 by sugaradmin

In this special episode on Obstructive Sleep Apnea our host, Dr. Neil Skolnik will discuss treatment of OSA. In Part 1 we discussed an overview of OSA, in Part 2 we discussed making the diagnosis, Part 3 was treatment, and in Part 4 we bring it all together with a case to explore clinical decision […]

Read More
DiabetesLeave a Comment on Diabetes Core Update : Special Edition

Predictors of Initial and Sustained Glycemic and Weight Response to Tirzepatide: A Post Hoc Analysis of SURPASS-4

September 20, 2025 by sugaradmin

This post hoc analysis assessed sustainability of lowered glycated hemoglobin (HbA1c) and weight with tirzepatide in people with type 2 diabetes and increased cardiovascular risk. Participants achieving HbA1c ≤48 mmol/mol (6.5%) or weight loss ≥10% at 52 weeks were evaluated for sustained glycemic or weight control and predictors of initial and sustained efficacy. For tirzepatide-treated […]

Read More
DiabetesLeave a Comment on Predictors of Initial and Sustained Glycemic and Weight Response to Tirzepatide: A Post Hoc Analysis of SURPASS-4

Concerted Actions of FoxO1 and PPARα in Hepatic Gene Expression and Metabolic Adaptation

September 20, 2025 by sugaradmin

Several transcription factors regulate the fasting response in liver. They include FoxO1 and FoxO3, CREB, C/EBP α/β, glucocorticoid receptor (GR), peroxisome proliferator–activated receptor-α (PPARα), FoxA2, hepatocyte nuclear factor-α (HNF4α), and others. Genome-wide chromatin occupancy studies revealed an unexpected overlap of FoxO1 and PPARα DNA binding sites at active intergenic and intron enhancers, yet their functional […]

Read More
DiabetesLeave a Comment on Concerted Actions of FoxO1 and PPARα in Hepatic Gene Expression and Metabolic Adaptation

Bidirectional Mendelian Randomization Indicates Causal Relationships Between Circulating Branched-Chain Amino Acids and Metabolic Health

September 20, 2025 by sugaradmin

Branched-chain amino acids (BCAAs) are essential nutrients for humans. An elevated circulating BCAA level has been associated with obesity and type 2 diabetes (T2D), but the causal role of BCAAs in metabolic health remains unclear. Using a two-sample bidirectional Mendelian randomization (MR) approach, we assessed the bidirectional causal effects of circulating BCAAs on body composition, […]

Read More
DiabetesLeave a Comment on Bidirectional Mendelian Randomization Indicates Causal Relationships Between Circulating Branched-Chain Amino Acids and Metabolic Health

The Heterogeneity of Type 1 Diabetes: Implications for Pathogenesis, Prevention, and Treatment—2024 Diabetes , Diabetes Care , and Diabetologia Expert Forum

September 20, 2025 by sugaradmin

This article summarizes the current understanding of the heterogeneity of type 1 diabetes from a June 2024 international Expert Forum organized by the editors of Diabetes, Diabetes Care, and Diabetologia. The Forum reviewed key factors contributing to the development and progression of type 1 diabetes and outlined specific, high-priority research questions. Knowledge gaps were identified, […]

Read More
DiabetesLeave a Comment on The Heterogeneity of Type 1 Diabetes: Implications for Pathogenesis, Prevention, and Treatment—2024 Diabetes , Diabetes Care , and Diabetologia Expert Forum

The Islet-1 Interaction Partner Rnf20 Regulates Glucose Homeostasis and Pancreatic β-Cell Identity

September 20, 2025 by sugaradmin

Diabetes is characterized by a loss of functional β-cell mass; therefore, identifying factors involved in establishing and preserving β-cells is critical to combat rising diabetes incidence. While transcription factors are crucial β-cell regulators, knowledge of coregulators facilitating gene expression is limited. Previously, we demonstrated that the islet-1 (Isl1) transcription factor forms complexes with ubiquitin ligases […]

Read More
DiabetesLeave a Comment on The Islet-1 Interaction Partner Rnf20 Regulates Glucose Homeostasis and Pancreatic β-Cell Identity

ALY688 Attenuates Iron-Induced ER Stress and Insulin Resistance via Activation of ER-Phagy

September 20, 2025 by sugaradmin

Iron overload (IO) is a common contributing factor to aspects of the metabolic syndrome (MetS), including insulin resistance. Mechanisms of IO-induced insulin resistance include elevated oxidative stress, endoplasmic reticulum (ER) stress and impaired autophagy. Using an Akt biosensor L6 skeletal muscle cell line, we found that the adiponectin receptor agonist ALY688 prevented impaired insulin signaling […]

Read More
DiabetesLeave a Comment on ALY688 Attenuates Iron-Induced ER Stress and Insulin Resistance via Activation of ER-Phagy

Low-to-Moderate Dosed Cranial Irradiation in Young Mice Induces Sex-Specific Metabolic Disturbances Later in Life

September 20, 2025 by sugaradmin

Survivors of childhood cancers who received high doses (40–60 Gy) of cranial irradiation (CI) have increased risks of developing obesity, type 2 diabetes, and metabolic syndrome (MetS). Here, we subjected mice to CI of 0, 0.5, or 2 Gy directed to the hypothalamus to explore the effects of low-to-moderate doses of CI on MetS risks. […]

Read More
DiabetesLeave a Comment on Low-to-Moderate Dosed Cranial Irradiation in Young Mice Induces Sex-Specific Metabolic Disturbances Later in Life

Posts navigation

Older posts
Newer posts

Recent Posts

  • FDA to Fast-Track Psychedelic Drugs for PTSD: What This Means
  • Ozempic Preserves Muscle Mass Better Than Mounjaro
  • Olympic Track and Field Star Allyson Felix Talks Rest and Recovery
  • Fructose in Ultra-Processed Foods May Raise Metabolic Disease
  • Trump Reclassifies Marijuana as Less Dangerous in Major Policy Shift

Recent Comments

  • A WordPress Commenter on SUCROSE: “PURE” ENERGY AT A PRICE

Archives

  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • November 2024
  • October 2024
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • May 2017

Categories

  • Celebrity Health
  • Diabetes
  • Food Choices
  • Fructose
  • General Sugar
  • Glucose
  • Health News
  • Insulin
  • Mental Health
  • Natural Unrefined Sugar
  • Stop Eating Sugar
  • Stop Killing Yourself
  • Sucrose
  • Sugar Science

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
  • Home
  • Diabetes
  • Health News
  • General Sugar
  • Food Choices
  • Insulin
  • Mental Health
  • Stop Eating Sugar
  • Stop Killing Yourself
  • Fructose
  • Sugar Science

© 2026 Sugar is a DRUG | Sugar Addiction Awareness